These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11736937)
1. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Mughal TI; Yong A; Szydlo RM; Dazzi F; Olavarria E; van Rhee F; Kaeda J; Cross NC; Craddock C; Kanfer E; Apperley J; Goldman JM Br J Haematol; 2001 Dec; 115(3):569-74. PubMed ID: 11736937 [TBL] [Abstract][Full Text] [Related]
2. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Dazzi F; Szydlo RM; Cross NC; Craddock C; Kaeda J; Kanfer E; Cwynarski K; Olavarria E; Yong A; Apperley JF; Goldman JM Blood; 2000 Oct; 96(8):2712-6. PubMed ID: 11023502 [TBL] [Abstract][Full Text] [Related]
3. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion. Otazú IB; Tavares Rde C; Hassan R; Zalcberg I; Tabak DG; Seuánez HN Leuk Res; 2002 Feb; 26(2):129-41. PubMed ID: 11755463 [TBL] [Abstract][Full Text] [Related]
4. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E; Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175 [TBL] [Abstract][Full Text] [Related]
5. Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. Olavarria E; Kanfer E; Szydlo R; Kaeda J; Rezvani K; Cwynarski K; Pocock C; Dazzi F; Craddock C; Apperley JF; Cross NC; Goldman JM Blood; 2001 Mar; 97(6):1560-5. PubMed ID: 11238091 [TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386 [TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia. Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776 [TBL] [Abstract][Full Text] [Related]
9. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140 [TBL] [Abstract][Full Text] [Related]
10. [Follow-up detection of M-bcr/abl and m-bcr/abl fusion transcripts in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation]. Qin YZ; Liu YR; Li JL; Fu JY; Chang Y; Ruan GR; Wang H; Qiu JY; Lu DP; Chen SS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):368-71. PubMed ID: 12962564 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Eder M; Battmer K; Kafert S; Stucki A; Ganser A; Hertenstein B Leukemia; 1999 Sep; 13(9):1383-9. PubMed ID: 10482989 [TBL] [Abstract][Full Text] [Related]
12. Lee SE; Choi SY; Kim SH; Song HY; Yoo HL; Lee MY; Kang KH; Hwang HJ; Jang EJ; Kim DW Korean J Intern Med; 2017 Jan; 32(1):125-136. PubMed ID: 27334764 [TBL] [Abstract][Full Text] [Related]
13. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase. Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437 [TBL] [Abstract][Full Text] [Related]
14. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse. Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438 [TBL] [Abstract][Full Text] [Related]